MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016

類似資料

• What is the role of antineoplastic drug safety in reimbursement decision making?
  著者:: A. S. Kolbin, 等
  出版事項: (2018-11-01)
• The social-economic burden of spinal muscular atrophy in Russia
  著者:: A. S. Kolbin, 等
  出版事項: (2021-02-01)
• Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy
  著者:: V. A. Lemeshko, 等
  出版事項: (2021-04-01)
• BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD
  著者:: A. S. Kolbin, 等
  出版事項: (2015-06-01)
• Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital
  著者:: A. S. Kolbin, 等
  出版事項: (2015-03-01)